$3,850.00 – $5,850.00
Published on: January 19, 2023The market for molecular cytogenetics is expected to reach USD 3.62 billion by 2025, increasing from 2020 to 2025 at a CAGR of 8.65 percent. The high incidence and large economic burden of genetic disorders and cancer and growing healthcare spending have resulted in the increasing use of molecular cytogenetic products in clinical and research laboratories, academic research institutes, and pharmaceutical and biotechnology companies.
1 Global Molecular Cytogenetics Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Molecular Cytogenetics Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Molecular Cytogenetics Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Molecular Cytogenetics Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Molecular Cytogenetics Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Molecular Cytogenetics Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Molecular Cytogenetics Market – By Product (Market Size – & million/billion)
8.1 Kits & Reagents
8.2 Instruments
8.3 Consumables
8.4 Software & Services
9 Global Molecular Cytogenetics Market – By Technique
9.1 Comparative Genomic Hybridization
9.2 Fluorescence in Situ Hybridization
9.3 In Situ Hybridization
9.4 Other
10 Global Molecular Cytogenetics Market – By Application
10.1 Genetic Disorders
10.2 Cancer
10.3 Personalized Medicine
10.4 Other
11 Global Molecular Cytogenetics Market – By End User
11.1 Clinical & Research Laboratories
11.2 Academic Research Institutes
11.3 Pharmaceutical and Biotechnology Companies
11.4 Other
12 Global Molecular Cytogenetics Market – By Geography (Market Size – & million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa
13 Global Molecular Cytogenetics Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships
14 Global Molecular Cytogenetics Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Abbott Laboratories, Inc.
14.3 Danaher Corporation
14.4 Agilent Technologies, Inc.
14.5 Applied Spectral Imaging
14.6 F. Hoffmann-LA Roche Ltd.
14.7 Thermo Fisher Scientific Inc.
14.8 Bio-Rad Laboratories, Inc.
14.9 Illumina, Inc.
14.10 Oxford Gene Technology (OGT)
14.11 Perkinelmer, Inc.
14.12 Company 11 & more
15 Global Molecular Cytogenetics Market – Appendix
15.1 Sources
15.2 Abbreviations
